drugset / Trial / NCT00023725

Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma

NCT00023725

RandomizedTreatment

Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as SU5416 may stop the growth of cancer by stopping blood flow to the tumor. It is not yet known if radiation therapy is more effective with or without SU5416 in treating soft tissue sarcoma. PURPOSE: Phase I/II trial to compare the effectiveness of radiation therapy with or without SU5416 in treating patients who have stage IB or stage IIA soft tissue sarcoma.

Timeline

Start
2001-08
Primary completion
Completion
2003-10

Drugs

EvaluationDrugModalityDoseRoute
Subject semaxanib Small molecule Intravenous

Indications